CME Group Inc - Ordinary Shares - Class A

CME Group Target Price

Analysts' average 12-month price target for CME Group is $320.

Get informed when a big investor buys or sells

+ Follow

Share Price

$315.5

Average Target Price

$316.08

0.2% upside

13 analysts in the last 4 months

High: $367 | Low: $270

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-10-22	Wells FargoDaniel Welden	$333	5.5% upside
2026-10-22	Piper Sandler	$330	4.6% upside
2026-10-22	BarclaysBenjamin Budish	$321	1.7% upside
2026-10-22	CLSA	$367	16.3% upside
2026-10-22	Morgan StanleyMichael Cyprys	$359	13.8% upside
2026-10-14	Wells FargoDaniel Welden	$315	0.2% downside
2026-10-09	Morgan Stanley	$337	6.8% upside
2026-10-07	Barclays	$281	10.9% downside
2026-10-05	UBSAlex Kramm	$270	14.4% downside
2026-10-01	Wells FargoDaniel Welden	$301	4.6% downside
2026-08-19	Deutsche Bank	$270	14.4% downside
2026-07-23	Morgan StanleyMichael Cyprys	$330	4.6% upside
2026-07-15	Piper Sandler	$295	6.5% downside
2026-07-10	Morgan Stanley	$324	2.7% upside
2026-07-06	UBSAlex Kramm	$260	17.6% downside
2026-06-17	Piper SandlerPatrick Moley	$320	1.4% upside
2026-06-15	Piper SandlerPatrick Moley	$329	4.3% upside
2026-06-11	Redburn Partners	$323	2.4% upside
2026-04-23	Barclays	$316	0.2% upside
2026-04-23	Morgan StanleyMichael Cyprys	$353	11.9% upside
2026-04-10	Morgan Stanley	$362	14.7% upside
2026-02-06	UBS	$310	1.7% downside
2026-02-05	BarclaysBenjamin Budish	$312	1.1% downside
2026-02-05	RBC CapitalAshish Sabadra	$302	4.3% downside
2026-02-05	Morgan Stanley	$340	7.8% upside
2026-01-15	Morgan Stanley	$319	1.1% upside
2025-12-22	Morgan StanleyMichael Cyprys	$320	1.4% upside
2025-12-12	Barclays	$304	3.6% downside
2025-10-23	UBSAlex Kramm	$280	11.3% downside
2025-10-23	Morgan StanleyMichael Cyprys	$314	0.5% downside
2025-10-23	Deutsche Bank	$300	4.9% downside
2025-10-13	Raymond JamesPatrick O'Shaughnessy	$307	2.7% downside
2025-10-08	Barclays	$280	11.3% downside
2025-10-01	Morgan Stanley	$312	1.1% downside
2025-09-08	UBSAlex Kramm	$285	9.7% downside
2025-07-24	BarclaysBenjamin Budish	$298	5.5% downside
2025-03-10	Raymond JamesPatrick O'Shaughnessy	$287	9% downside
2024-10-24	BarclaysBenjamin Budish	$231	26.8% downside
2024-10-24	OppenheimerOwen Lau	$258	18.2% downside
2024-10-03	CitigroupChristopher Allen	$250	20.8% downside
2024-09-26	RBC CapitalAshish Sabadra	$235	25.5% downside
2024-09-03	Bank of America SecuritiesCraig Siegenthaler	$177	43.9% downside
2024-07-25	Deutsche BankBrian Bedell	$193	38.8% downside
2024-07-25	Piper SandlerPatrick Moley	$225	28.7% downside
2024-07-25	BarclaysBenjamin Budish	$209	33.8% downside
2024-06-05	UBSAlex Kromm	$250	20.8% downside
2024-04-25	Rosenblatt SecuritiesAndrew Bond	$187	40.7% downside
2024-04-25	BarclaysBenjamin Budish	$228	27.7% downside
2024-04-05	Deutsche BankBrian Bedell	$210	33.4% downside
2023-02-07	Credit Suisse	$198	37.2% downside

CME Group (CME) FAQ

CME Group posts a target price of $320. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $320 for CME means covering analysts, on average, see the stock 0.2% upside of $315.5 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for CME's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; CME Group's other metric pages and overview cover the third.

Judging CME Group against Finance peers is usually better than using a market-wide rule of thumb. Business models inside Finance are more comparable, which makes gaps in target price easier to interpret. Start with $320 here, then scan peer and history charts to see if the gap is persistent.